
About Roselabs Finance
Roselabs Finance is a publicly listed company based in Mumbai (India) founded in 1995. Real estate investments are managed by Roselabs Finance in India. Its Indian entity Roselabs Finance Limited reported revenue of βΉ1.21 Cr. Roselabs Finance offers products and services including Real Estate Development Services. Its focus areas include Investment Industry and Real Estate Funds.
Company details
Roselabs Finance was established in 1995 as a real estate investment firm based in Mumbai, India. Operations focus on managing investments within the property sector, including portfolio development and asset allocation for clients. Services encompass advisory on real estate opportunities and financial structuring for property acquisitions. The firm operates primarily in the Indian market, with emphasis on urban development projects in key regions.
- Headquarters Mumbai, India
- Stage Public
- SectorsFinancial Services
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website roselabsfinancelimited.in
- Legal Name Roselabs Finance Ltd.
- Market Cap₹21.00 Cr
ROSELABS · BSE
- Share Price₹19.95
-5.00% today
- Revenue₹1.21 Cr
FY 2025-26 · +70.4% YoY
- EBITDA−₹0.20 Cr
Margin -16.5%
- Net Profit−₹0.31 Cr
FY 2025-26 · -10.7% YoY
Associated legal entities of Roselabs Finance
Roselabs Finance operates through Roselabs Finance Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Roselabs Finance Limited Listed CIN L70100MH1995PLC318333 | Active | 04 Jan 1995 | Mumbai, Maharashtra | ₹1.2 Cr | 6 | View details |
Products & Services of Roselabs Finance
Roselabs Finance offers a comprehensive portfolio of products and services, including Real Estate Development Services.
Offers development and management of property projects in India
Board of directors of Roselabs Finance Limited (Roselabs Finance)
Roselabs Finance Limited is the primary company behind Roselabs Finance. The board of Roselabs Finance Limited currently have 4 directors; the longest-serving is Sanjyot Rangnekar Nilesh, appointed in 2017. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjyot Rangnekar Nilesh DIN 07128992 | Director | 19 Apr 2017 | 9 yrs 7 mo | Roselabs Finance Limited |
| Prakash Lavji Vaghela DIN 07768595 | Director | 07 Feb 2018 | 8 yrs 9 mo | Roselabs Finance Limited |
| Mayank Chimanbhai Padiya DIN 07145403 | Director | 21 May 2018 | 8 yrs 6 mo | Roselabs Finance Limited |
| Raghava Reddy Balineni DIN 09185972 | Managing Director | 31 May 2021 | 5 yrs 5 mo | Roselabs Finance Limited |
IPO & Listings of Roselabs Finance
Roselabs Finance is a publicly listed company on the BSE with ticker symbol ROSELABS in India, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date18 Dec 2000
- Listed onBSE: 531324
- Listed entityRoselabs Finance Ltd.
- Exchange sectorFinance
- ISININE475C01012
- Share price₹18.24 (+3.34% on the day) · 2026-10-12
- Market capitalisation₹18.2 Cr
- EPS (diluted, trailing year)₹-0.31
- Volume (last session)14,485
Financials of Roselabs Finance
Exchange-reported figures of Roselabs Finance Limited, the listed company behind Roselabs Finance (BSE: ROSELABS).
Financial Highlights
FY 2025-26 Β· StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1.21 | 0.71 | 1.14 | 0.00 | 0.00 | 0.16 | 0.00 |
| Revenue growth | +70.4% | -37.7% | - | - | -100.0% | - | - |
| EBITDA | (0.20) | (0.30) | (0.18) | (0.69) | (0.44) | (2.75) | (0.14) |
| EBITDA margin | -16.5% | -42.3% | -15.8% | - | - | -1718.8% | - |
| Profit before tax | (0.20) | (0.28) | (0.14) | 2.06 | (0.44) | (2.75) | (0.14) |
| Net profit | (0.31) | (0.28) | (0.14) | (0.55) | (0.44) | 0.17 | (0.14) |
| Net profit margin | -25.6% | -39.4% | -12.3% | - | - | +106.3% | - |
| EPS (βΉ) | (0.31) | (0.29) | (0.13) | 2.02 | (0.44) | (2.57) | (0.14) |
| Balance sheet | |||||||
| Total assets | 0.04 | 0.21 | 0.13 | 0.02 | (1.39) | (1.32) | 1.18 |
| Net worth | (5.03) | (4.73) | (4.44) | (4.30) | (6.32) | (5.88) | (3.31) |
| Total debt | 5.07 | 4.93 | 4.57 | 4.33 | 4.93 | 4.57 | 4.49 |
| Cash & bank | 0.05 | 0.12 | 0.07 | 0.00 | 0.03 | 0.05 | 0.01 |
| Net working capital | 0.03 | 0.10 | 0.02 | (0.09) | (1.55) | (1.47) | 0.00 |
| Cash flow | |||||||
| Cash from operations | (0.20) | (0.32) | (0.18) | 0.58 | (0.38) | (0.20) | (0.42) |
| Cash from investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 |
| Cash from financing | 0.14 | 0.37 | 0.24 | (0.60) | 0.36 | 0.07 | 0.42 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.21 | 0.00 | 0.00 | 0.71 | 0.00 |
| Revenue growth (YoY) | - | - | -100.0% | - | - | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 0.06 | 0.05 | 0.05 | 1.24 | 0.06 | 0.05 | 0.75 | 0.11 |
| EBITDA | (0.06) | (0.05) | (0.05) | (0.03) | (0.06) | (0.05) | (0.04) | (0.11) |
| EBITDA margin | - | - | - | -2.5% | - | - | -5.6% | - |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.06) | (0.05) | (0.05) | (0.03) | (0.06) | (0.05) | (0.04) | (0.11) |
| Tax | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.21 | 0.00 | 0.00 | 0.71 | 0.00 |
| Revenue growth (YoY) | - | - | -100.0% | - | - | - | - | - |
| Other income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total expenses | 0.06 | 0.05 | 0.05 | 1.24 | 0.06 | 0.05 | 0.75 | 0.11 |
| EBITDA | (0.06) | (0.05) | (0.05) | (0.03) | (0.06) | (0.05) | (0.04) | (0.11) |
| EBITDA margin | - | - | - | -2.5% | - | - | -5.6% | - |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.06) | (0.05) | (0.05) | (0.03) | (0.06) | (0.05) | (0.04) | (0.11) |
| Tax | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.21 | 0.71 | 1.14 | 0.00 | 0.00 | 0.16 | 0.00 |
| Revenue growth | +70.4% | -37.7% | - | - | -100.0% | - | - |
| Other income | 0.00 | 0.02 | 0.04 | 2.75 | 0.00 | 0.00 | 0.00 |
| Total expenses | 1.41 | 1.01 | 1.32 | 0.69 | 0.44 | 2.91 | 0.14 |
| Employee cost | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | 0.03 | 0.04 |
| EBITDA | (0.20) | (0.30) | (0.18) | (0.69) | (0.44) | (2.75) | (0.14) |
| EBITDA margin | -16.5% | -42.3% | -15.8% | - | - | -1718.8% | - |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | (0.20) | (0.28) | (0.14) | 2.06 | (0.44) | (2.75) | (0.14) |
| Tax | 0.11 | 0.00 | 0.00 | 0.05 | 0.00 | (0.17) | 0.00 |
| Net profit | (0.31) | (0.28) | (0.14) | (0.55) | (0.44) | 0.17 | (0.14) |
| Net profit margin | -25.6% | -39.4% | -12.3% | - | - | +106.3% | - |
| EPS (βΉ) | (0.31) | (0.29) | (0.13) | 2.02 | (0.44) | (2.57) | (0.14) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserves & surplus | (15.03) | (14.73) | (14.44) | (14.30) | (16.32) | (15.88) | (13.31) |
| Shareholders' funds (net worth) | (5.03) | (4.73) | (4.44) | (4.30) | (6.32) | (5.88) | (3.31) |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Unsecured loans | 5.07 | 4.93 | 4.57 | 4.33 | 4.93 | 4.57 | 4.49 |
| Total debt | 5.07 | 4.93 | 4.57 | 4.33 | 4.93 | 4.57 | 4.49 |
| Total liabilities | 0.04 | 0.21 | 0.13 | 0.02 | (1.39) | (1.32) | 1.18 |
| Assets | |||||||
| Gross block | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net block | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sundry debtors | 0.00 | 0.00 | 1.34 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash & bank balances | 0.05 | 0.12 | 0.07 | 0.00 | 0.03 | 0.05 | 0.01 |
| Loans & advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total current assets | 0.05 | 0.12 | 1.41 | 0.00 | 0.03 | 0.05 | 0.01 |
| Total current liabilities | 0.02 | 0.02 | 1.39 | 0.09 | 1.58 | 1.52 | 0.01 |
| Net working capital | 0.03 | 0.10 | 0.02 | (0.09) | (1.55) | (1.47) | 0.00 |
| Total assets | 0.04 | 0.21 | 0.13 | 0.02 | (1.39) | (1.32) | 1.18 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.12 | 0.07 | 0.00 | 0.03 | 0.05 | 0.01 | 0.01 |
| Net cash from operating activities | (0.20) | (0.32) | (0.18) | 0.58 | (0.38) | (0.20) | (0.42) |
| Net cash from investing activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.00 |
| Net cash from financing activities | 0.14 | 0.37 | 0.24 | (0.60) | 0.36 | 0.07 | 0.42 |
| Net change in cash | (0.06) | 0.05 | 0.06 | (0.02) | (0.02) | 0.04 | 0.00 |
| Closing cash | 0.05 | 0.12 | 0.07 | 0.00 | 0.03 | 0.05 | 0.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +70.4% | -37.7% | - | - | -100.0% | - | - |
| EBITDA growth | +33.3% | -66.7% | +73.9% | -56.8% | +84.0% | -1864.3% | - |
| PBT growth | +28.6% | -100.0% | - | +9998.0% | +84.0% | -1864.3% | +65.9% |
| Net income growth | -10.7% | -100.0% | +74.6% | -25.0% | -358.8% | +221.4% | - |
| Revenue CAGR (3Y) | - | - | +92.4% | - | - | -62.5% | -100.0% |
| EBITDA CAGR (3Y) | -33.8% | -12.0% | -59.7% | +70.2% | +16.3% | - | - |
| Profitability & leverage | |||||||
| Net income margin | -25.6% | -39.4% | -12.3% | - | - | -1612.5% | - |
| Return on capital employed | 0.0% | 0.0% | 0.0% | -8.2% | 0.0% | 0.0% | 0.0% |
| Return on net worth | 0.0% | 0.0% | 0.0% | -29.4% | 0.0% | 0.0% | 0.0% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debtors turnover | 0.00 | 1.06 | 1.70 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (βΉ) | (0.31) | (0.29) | (0.13) | 2.02 | (0.44) | (2.57) | (0.14) |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | (5.03) | (4.73) | (4.44) | (4.30) | (6.32) | (5.88) | (3.31) |
Top companies in Real Estate & Property Investment Funds
2 companies that operate in the same segment as Roselabs Finance (Real Estate & Property Investment Funds) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Mutual fund management and investment services in India. | 2011 | Mumbai, Maharashtra, India | USD 256.02 K | |||
Full-service corporate advisory services are provided by Emkay. | 1995 | Mumbai, Maharashtra, India | USD 41.78 M | 534 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Roselabs Finance
Complete news archive for Roselabs Finance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Roselabs Finance
Roselabs Finance was founded in 1995.
Roselabs Finance is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Roselabs Finance, Roselabs Finance Limited, reported revenue of βΉ1.21 Cr for FY 2026, up 70% year on year.
Roselabs Finance was established in 1995 as a real estate investment firm based in Mumbai, India. Operations focus on managing investments within the property sector, including portfolio development and asset allocation for clients. Services encompass advisory on real estate opportunities and financial structuring for property acquisitions. The firm operates primarily in the Indian market, with emphasis on urban development projects in key regions.
Roselabs Finance offers Real Estate Development Services.
Yes, Roselabs Finance is publicly traded on BSE under the ticker symbol ROSELABS.
Roselabs Finance operates through Roselabs Finance Limited.
The legal entities of Roselabs Finance currently have 6 directors, including Prakash Lavji Vaghela, Mayank Chimanbhai Padiya, Raghava Reddy Balineni and others.
